Ethyl-2,2-difluoro-2-(3,4-dichlorophenyl)acetate, 95.0%, 1g

2-Hydroxymethyl-benzoic acid tert-butyl ester, 95.0%, 1g

3-Chloro-2-ethynyl-5-(trifluoromethyl)pyridine, 98+%, 1g

Methyl 4-(2-methyloxiran-2-yl)benzoate, 250mg

(4-Hydroxy-3-methylphenyl)boronic acid, 95.0%, 1g

10H-Dibenzo[b,e][1,4]oxaborinin-10-ol, 97%, 5g

Ethyl 2-methyl-6,7-dihydro-5h-pyrrolizine-3-carboxylate, 98%, 5g

(5-Phenyl-1,3,4-oxadiazol-2-yl)methylamine, 95.0%, 5g

(S)-1-(3-Nitrophenyl)ethanol, 97%, 5g

(R)-Phenyl(4-(trifluoromethyl)phenyl)methanamine hydrochloride, 97%, 250mg

(1-Methylpiperidin-4-yl)boronic acid, 98%, 1g

Alcyne-dATP, ≥95%, 500 µl, emballage plastique.

3,4-Dihydroxy-5-nitrobenzaldehyde, 95.0%, 10g